We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App

Non-Invasive Diagnostic Test Improves Detection of Oral Cancer

By LabMedica International staff writers
Posted on 04 Apr 2023
Print article
Image: PANDORA is a non-invasive diagnostic test developed for detecting oral cancer (Photo courtesy of Pexels)
Image: PANDORA is a non-invasive diagnostic test developed for detecting oral cancer (Photo courtesy of Pexels)

Oral squamous cell carcinoma (OSCC) is a highly prevalent type of cancer that affects the lining of the mouth and throat, and is strongly associated with lifestyle factors such as smoking, alcohol use, or poor oral hygiene. Symptoms of OSCC include persistent mouth sores, difficulty swallowing, and changes in speech. The disease can be successfully treated if detected early, but prognosis is poor if diagnosed at a late stage. Oral epithelial dysplasia (OED) is a precursor condition to OSCC, in which the lining of the mouth shows abnormal changes in shape, size, and arrangement due to lifestyle factors such as smoking or alcohol use. OED can progress to oral cancer if not detected and treated early. With more than three hundred thousand people worldwide being diagnosed with oral cancer, the mortality rate of around 50% is alarming, indicating a lack of effective tools for early detection.

Now, scientists at the University of Surrey (Guildford, UK) have developed PANDORA, a proof-of-concept test that demonstrated over 92% accuracy in identifying patients with OSCC and over 80% accuracy in detecting pre-cancer or OED. The study involved taking cell samples from a test group of 40 people with OSCC and OED, as well as 79 people without cancer, including those with other benign lesions. The DEPtech 3DEP analyzer, with a unique set-up protocol, was utilized to measure and analyze the patient's cells. Since samples can be obtained at a dentist's office and sent for analysis via post, the test can be used in primary care to identify patients requiring specialist care.

“Over three hundred thousand people are diagnosed with oral cancer worldwide – a disease with an alarming mortality rate of around 50%,” said Dr. Fatima Labeed, co-author of the study and Senior Lecturer in Human Biology from the University of Surrey. “This suggests that the scientific community doesn't have the tools available to identify oral cancer early enough, and we hope that PANDORA paves the way for more effective clinical diagnostic tools for this terrible disease.”

Related Links:
University of Surrey

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
TORCH Panel Rapid Test
Rapid TORCH Panel Test

Print article


Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more


view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more


view channel
Image: The AI predictive model identifies the most potent cancer killing immune cells for use in immunotherapies (Photo courtesy of Shutterstock)

AI Predicts Tumor-Killing Cells with High Accuracy

Cellular immunotherapy involves extracting immune cells from a patient's tumor, potentially enhancing their cancer-fighting capabilities through engineering, and then expanding and reintroducing them into the body.... Read more


view channel
Image: The T-SPOT.TB test is now paired with the Auto-Pure 2400 liquid handling platform for accurate TB testing (Photo courtesy of Shutterstock)

Integrated Solution Ushers New Era of Automated Tuberculosis Testing

Tuberculosis (TB) is responsible for 1.3 million deaths every year, positioning it as one of the top killers globally due to a single infectious agent. In 2022, around 10.6 million people were diagnosed... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.